Cargando…
Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis
As heart failure, coronary artery disease and atrial fibrillation all bring a risk of thrombosis, anti-thrombotic therapy is recommended. Despite such treatment, major cardiovascular events such as myocardial infarction and stroke still occur, implying inadequate suppression of thrombus formation. A...
Autores principales: | Lau, Y. C., Xiong, Q., Ranjit, P., Lip, G. Y. H., Blann, A. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912975/ https://www.ncbi.nlm.nih.gov/pubmed/26942726 http://dx.doi.org/10.1007/s11239-016-1344-5 |
Ejemplares similares
-
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
por: Spinthakis, Nikolaos, et al.
Publicado: (2019) -
Biomarkers of Inflammation, Thrombogenesis, and Collagen Turnover in Patients With Atrial Fibrillation
por: Jabati, Sallu, et al.
Publicado: (2018) -
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura
por: Alwan, Ferras, et al.
Publicado: (2021) -
Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2013) -
Echocardiographic and Electrocardiographic Determinants of Atrial Cardiomyopathy Identify Patients with Atrial Fibrillation at Risk for Left Atrial Thrombogenesis
por: Huang, Taiyuan, et al.
Publicado: (2022)